| Journal | International journal of molecular sciences |
| Study Type | Clinical Study |
| Population | Human participants |
Understanding CB2 receptor genetics provides mechanistic insight into individual variation in cannabis response. This research may eventually inform personalized medicine approaches, though clinical applications remain distant.
This study examines genetic encoding of the CB2 receptor, a G-protein-coupled receptor primarily expressed in immune cells and peripheral tissues. CB2 receptors modulate immune function and inflammation, distinct from CB1’s central nervous system effects. The research explores genetic variants that may influence receptor function and expression. However, without access to specific methodology and results, the clinical relevance of particular findings cannot be assessed.
“Genetic studies of cannabinoid receptors are scientifically interesting but don’t change my prescribing today. We’re still years away from practical pharmacogenomic testing that would meaningfully guide cannabis dosing or strain selection.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
This study item was assembled from normalized source metadata and pipeline scoring.